Discovering DNA: Friedrich Miescher and the early years of nucleic acid research.

Center for Brain Research, Medical University of Vienna, Spitalgasse 4, 1090, Vienna, Austria,
Human Genetics (Impact Factor: 4.63). 02/2008; 122(6):565-81. DOI: 10.1007/s00439-007-0433-0
Source: PubMed

ABSTRACT In the winter of 1868/9 the young Swiss doctor Friedrich Miescher, working in the laboratory of Felix Hoppe-Seyler at the University of Tübingen, performed experiments on the chemical composition of leukocytes that lead to the discovery of DNA. In his experiments, Miescher noticed a precipitate of an unknown substance, which he characterised further. Its properties during the isolation procedure and its resistance to protease digestion indicated that the novel substance was not a protein or lipid. Analyses of its elementary composition revealed that, unlike proteins, it contained large amounts of phosphorous and, as Miescher confirmed later, lacked sulphur. Miescher recognised that he had discovered a novel molecule. Since he had isolated it from the cells' nuclei he named it nuclein, a name preserved in today's designation deoxyribonucleic acid. In subsequent work Miescher showed that nuclein was a characteristic component of all nuclei and hypothesised that it would prove to be inextricably linked to the function of this organelle. He suggested that its abundance in tissues might be related to their physiological status with increases in "nuclear substances" preceding cell division. Miescher even speculated that it might have a role in the transmission of hereditary traits, but subsequently rejected the idea. This article reviews the events and circumstances leading to Miescher's discovery of DNA and places them within their historic context. It also tries to elucidate why it was Miescher who discovered DNA and why his name is not universally associated with this molecule today.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Computational Biology and Chemistry j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / c o m p b i o l c h e m a b s t r a c t Engineering contributions have played an important role in the rise and evolution of cellular biology. Engineering technologies have helped biologists to explore the living organisms at cellular and molecular levels, and have created new opportunities to tackle the unsolved biological problems. There is now a growing demand to further expand the role of engineering in cellular biology research. For an engineer to play an effective role in cellular biology, the first essential step is to understand the cells and their components. However, the stumbling block of this step is to comprehend the information given in the cellular biology literature because it best suits the readers with a biological background. This paper aims to overcome this bottleneck by describing the human cell components as micro-plants that form cells as micro-bio-factories. This concept can accelerate the engineers' comprehension of the subject. In this paper, first the structure and function of different cell components are described. In addition, the engineering attempts to mimic various cell components through numerical modelling or physical implementation are highlighted. Next, the interaction of different cell components that facilitate complicated chemical processes, such as energy generation and protein synthesis, are described. These complex interactions are translated into simple flow diagrams, generally used by engineers to represent multi-component processes.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Telomerase is an attractive drug target to develop new generation drugs against cancer. Telomere appears from the chromosomal termini and protects it from the double-stranded DNA degradation. A short telomere promotes genomic instability like end-to-end fusion and regulates over-expression of the telomere repairing enzyme telomerase. Telomerase maintains the telomere length which may lead to genetically abnormal situations leading to cancer. Thus, the design and synthesis of efficient telomer aseinhibitor is a viable strategy toward the anticancer drug development. Accordingly small molecule induced stabilization of the G-quadruplex structure formed by the human telomeric DNA is an area of contemporary scientific art. Several such compounds efficiently stabilize the G-quadruplex forms of nucleic acid which often leads to telomerase inhibition. This feature article presents the discovery and development of telomere structure, function and evolution in the telomere targeted anticancer drug design and incorporates the recent advances in this area and discuss the pros and cones in the methods and prospects for future.
    Chemical Communications 01/2014; · 6.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nanotechnology is a rapidly expanding research area, and it is believed that the unique properties of molecules at the nano-scale will prove to be of substantial benefit to mankind, especially so in medicine and electronics. Here we use applied mathematical modelling exploiting the basic principles of mechanics and the 6-12 Lennard-Jones potential function together with the continuum approximation, which assumes that intermolecular interactions can be approximated by average atomic surface densities. We consider the equilibrium offset positions for both single-strand and double-strand DNA molecules inside a single-walled carbon nanotube, and we predict offset positions with reference to the cross-section of the carbon nanotube. For the double-strand DNA, the potential energy is determined for the general case for any helical phase angle ϕ, but we also consider a special case when ϕ = π, which leads to a substantial simplification in the analytical expression for the energy. As might be expected, our results confirm that the global minimum energy positions for a single-strand DNA molecule and a double-strand DNA molecule will lie off axis and they become closer to the tube wall as the radius of the tube increases.
    Biophysics of Structure and Mechanism 11/2013; · 2.44 Impact Factor

Full-text (2 Sources)

Available from
May 21, 2014